Journal
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 81, Issue 1, Pages 46-48Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2022.10.018
Keywords
aficamten; cardiac myosin inhibitor; hypertrophic cardiomyopathy; N-terminal pro-B type natriuretic peptide; obstructive cardiomyopathy